Original Research
Building laboratory capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004–2012
Submitted: 06 May 2014 | Published: 14 May 2015
About the author(s)
Donald J. Hamel, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, United StatesJean-Louis Sankalé, Globomics, LLC, Decatur, GA, United States
Jay O. Samuels, AIDS Prevention Initiative in Nigeria Ltd. Gte., Abuja, Nigeria
Abdoulaye D. Sarr, Global AIDS Program Malawi, Centers for Disease Control and Prevention, NICO House Lilongwe 3, Malawi
Beth Chaplin, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, United States
Eke Ofuche, AIDS Prevention Initiative in Nigeria Ltd. Gte., Abuja, Nigeria
Seema T. Meloni, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, United States
Prosper Okonkwo, AIDS Prevention Initiative in Nigeria Ltd. Gte., Abuja, Nigeria
Phyllis J. Kanki, Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA, United States
Abstract
Introduction: From 2004–2012, the Harvard/AIDS Prevention Initiative in Nigeria, funded through the US President’s Emergency Plan for AIDS Relief programme, scaled up HIV care and treatment services in Nigeria. We describe the methodologies and collaborative processes developed to improve laboratory capacity significantly in a resource-limited setting. These methods were implemented at 35 clinic and laboratory locations.
Methods: Systems were established and modified to optimise numerous laboratory processes. These included strategies for clinic selection and management, equipment and reagent procurement, supply chains, laboratory renovations, equipment maintenance, electronic data management, quality development programmes and trainings.
Results: Over the eight-year programme, laboratories supported 160 000 patients receiving HIV care in Nigeria, delivering over 2.5 million test results, including regular viral load quantitation. External quality assurance systems were established for CD4+ cell count enumeration, blood chemistries and viral load monitoring. Laboratory equipment platforms were improved and standardised and use of point-of-care analysers was expanded. Laboratory training workshops supported laboratories toward increasing staff skills and improving overall quality. Participation in a World Health Organisation-led African laboratory quality improvement system resulted in significant gains in quality measures at five laboratories.
Conclusions: Targeted implementation of laboratory development processes, during simultaneous scale-up of HIV treatment programmes in a resource-limited setting, can elicit meaningful gains in laboratory quality and capacity. Systems to improve the physical laboratory environment, develop laboratory staff, create improvements to reduce costs and increase quality are available for future health and laboratory strengthening programmes. We hope that the strategies employed may inform and encourage the development of other laboratories in resource-limited settings.
Keywords
Metrics
Total abstract views: 6451Total article views: 9534
Crossref Citations
1. HIV viral load scale-up
Sergio Carmona, Trevor Peter, Leigh Berrie
Current Opinion in HIV and AIDS vol: 12 issue: 2 first page: 157 year: 2017
doi: 10.1097/COH.0000000000000352